These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Ioanas M; Ferrer M; Cavalcanti M; Ferrer R; Ewig S; Filella X; de la Bellacasa JP; Torres A Crit Care Med; 2004 Apr; 32(4):938-45. PubMed ID: 15071382 [TBL] [Abstract][Full Text] [Related]
45. Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Mentzelopoulos SD; Pratikaki M; Platsouka E; Kraniotaki H; Zervakis D; Koutsoukou A; Nanas S; Paniara O; Roussos C; Giamarellos-Bourboulis E; Routsi C; Zakynthinos SG Intensive Care Med; 2007 Sep; 33(9):1524-32. PubMed ID: 17549457 [TBL] [Abstract][Full Text] [Related]
46. Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality. Myny D; Depuydt P; Colardyn F; Blot S Acta Clin Belg; 2005; 60(3):114-21. PubMed ID: 16156370 [TBL] [Abstract][Full Text] [Related]
47. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Nseir S; Di Pompeo C; Soubrier S; Cavestri B; Jozefowicz E; Saulnier F; Durocher A Chest; 2005 Sep; 128(3):1650-6. PubMed ID: 16162771 [TBL] [Abstract][Full Text] [Related]
49. Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Hallal A; Cohn SM; Namias N; Habib F; Baracco G; Manning RJ; Crookes B; Schulman CI Surg Infect (Larchmt); 2007 Feb; 8(1):73-82. PubMed ID: 17381399 [TBL] [Abstract][Full Text] [Related]
50. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Ibrahim EH; Tracy L; Hill C; Fraser VJ; Kollef MH Chest; 2001 Aug; 120(2):555-61. PubMed ID: 11502658 [TBL] [Abstract][Full Text] [Related]
51. Infections in a surgical intensive care unit of a university hospital in Greece. Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663 [TBL] [Abstract][Full Text] [Related]
52. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR; Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919 [TBL] [Abstract][Full Text] [Related]
53. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India. Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645 [TBL] [Abstract][Full Text] [Related]
54. The Multiple Organ Dysfunction Score as a descriptor of patient outcome in septic shock compared with two other scoring systems. Jacobs S; Zuleika M; Mphansa T Crit Care Med; 1999 Apr; 27(4):741-4. PubMed ID: 10321663 [TBL] [Abstract][Full Text] [Related]
55. Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality. Peña C; Gómez-Zorrilla S; Oriol I; Tubau F; Dominguez MA; Pujol M; Ariza J Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):413-20. PubMed ID: 23344827 [TBL] [Abstract][Full Text] [Related]
56. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia. Fish DN; Kiser TH Pharmacotherapy; 2013 Oct; 33(10):1022-34. PubMed ID: 23744833 [TBL] [Abstract][Full Text] [Related]
57. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Rello J; Ausina V; Ricart M; Castella J; Prats G Chest; 1993 Oct; 104(4):1230-5. PubMed ID: 8404198 [TBL] [Abstract][Full Text] [Related]
58. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Vallés J; Rello J; Ochagavía A; Garnacho J; Alcalá MA Chest; 2003 May; 123(5):1615-24. PubMed ID: 12740282 [TBL] [Abstract][Full Text] [Related]
59. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916 [TBL] [Abstract][Full Text] [Related]